More About MS (2025 Part 2)

More About MS (2025 Part 2)

More About MS, Patient, Resources

This activity is jointly provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education and is supported by Sanofi, Novartis, Genentech, TG Therapeutics, Biogen, and MED Serono.

This recording is part of the 2025 More About MS Program, a patient-centered event held in conjunction with the annual CMSC Meeting. The program took place on Friday, May 30, 2025, at the Sheraton Phoenix Downtown. Can Do MS was proud to partner with Barrow Neurological Institute for this year’s event.

Click here to view

Rachelle Ramirez

Biosimilar medicines – An educational package for the MS nurse

Ask the Experts

MS Teamworks

More About MS (2025 Part 1)

More About MS, Patient, Resources

More About MS (2024)

More About MS, Patient, Resources

More ABout MS (2023)

More About MS, Patient, Resources

Updates in Management of Headache and Facial Pain What the MS Clinician Needs to Know

International Perspectives on the Importance of Multidisciplinary Approach to Nutrition Care for MS

Basic Science, Cultural

The Power of Prevention A Focus on Immunology, Vaccine Recommendations and Infection Management

Basic Science, COVID-19

Best Practices in Multiple Sclerosis Therapies

Best Practices, Resources

Updates in Cognition and Multiple Sclerosis: Expert Guidance on Management Across on the Continuum of the Disease

Cognition and Psychosocial, Resources

Best Practices Guideline on the Use of Neurofilament

CMSC Consensus Statements, Disease Modifying Therapies, Guidelines from other organizations

Thinking Critically about World Wide Web Resources

2021 Standardized MRI Protocol Cards

Sister’s Hope Foundation

Patient, Resources

2021 MAGNIMS-CMSC-NAIMS MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-up of MS

CMSC Consensus Statements, MRI

More About MS (2022)

More About MS, Patient, Resources

Best Practices in Multiple Sclerosis Therapies (May 2022)

Best Practices, Resources

Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies

Elucidating the Association of Epstein-Barr Virus and Multiple Sclerosis

Basic Science, Resources

More About MS (2021)

More About MS, Patient, Resources

2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

CMSC Consensus Statements, MRI

Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry

Basic Science, COVID-19, Resources

CMSC Consensus Statement on Neurofilament Biomarkers in Multiple Sclerosis

CMSC Consensus Statements, Disease Modifying Therapies

The Multiple Sclerosis Journey

Patient, Resources

An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation Strategies

Guidance for the Use of Disease Modifying Therapies During the COVID-19 pandemic

COVID-19, Disease Modifying Therapies, Guidelines from other organizations

2019 CMSC Practical Guidelines for the Selection of Disease-Modifying Therapies in Multiple Sclerosis

CMSC Consensus Statements, Disease Modifying Therapies

Comprehensive Palliative Care in MS: CMSC Consensus Statement and Proposed Guidelines

Best Practices, CMSC Consensus Statements, Recommendations For Care, Resources

Practice Guideline Update Summary: Vaccine-preventable Infections and Immunization in Multiple Sclerosis

Best Practices, Guidelines from other organizations, Resources

The American Academy of Neurology Patient Summary and Clinician Summary of an Evidence-based Guideline: Assessment and Management of Psychiatric Disorders in Individuals with Multiple Sclerosis

Cognition and Psychosocial, Resources

More About MS (2019)

More About MS, Patient, Resources

A Survey of Risk Tolerance to Multiple Sclerosis Therapies

Disease Modifying Therapies

2018 CMSC MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-up of MS

CMSC Consensus Statements, MRI

2017 Proposed MRI Revised Guidelines for Diagnosis and Follow-up of MS (UPDATED)

CMSC Consensus Statements, MRI

2017 Proposed MRI Revised Guidelines for Diagnosis and Follow-up of MS

CMSC Consensus Statements, MRI

Addressing Concerns Regarding the Use of Gadolinium in a Standardized MRI Protocol for the Diagnosis and Follow-Up of Multiple Sclerosis

Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis

CMSC Consensus Statements, MRI

Essential Elements: My Personal Journal

Patient, Resources

Summary of Evidence-Based Guideline: Complementary and Alternative Medicine in Multiple Sclerosis

Best Practices, Guidelines from other organizations, Resources

Summary of Evidence-Based Guideline for Patients and their Families: Complementary and Alternative Medicine for Multiple Sclerosis

Patient, Resources

AAN Issues New Guideline on Complementary and Alternative Medicine in MS

Disease Modifying Therapies

Home-Based Exercise Program and Fall-Risk Reduction in Older Adults with Multiple Sclerosis: Phase 1 Randomized Controlled Trial

Rehabilitation, Resources

Summary of Evidence-Based Guideline: Assessment and Management of Psychiatric Disorders in Individuals with Multiple Sclerosis

Best Practices, Guidelines from other organizations, Resources

Aquatic Exercise & Multiple Sclerosis: A Healthcare Professional’s Guide

Rehabilitation, Resources

NARCOMS Registry

Patient, Resources, Sticky

NARCOMS Now (Publication)

Patient, Resources, Sticky

2009 CMSC MRI Protocol for the Diagnosis and Follow-up of MS

The Effects of Isoniazid on Patients with Multiple Sclerosis

Basic Science, Resources

Some Contributions of the Department of Veterans Affairs to the Epidemiology of Multiple Sclerosis

Basic Science, Resources

MS in Uruguay

Basic Science, Resources

Argentine Patagonia: Prevalence and Clinical Features of Multiple Sclerosis

Basic Science, Resources

Argentine Patagonia: prevalence and clinical features of multiple sclerosis

MS in Uruguay

Considerations in the Evaluation of Cognition in Multiple Sclerosis

Cognition and Psychosocial, Resources

The Basics of Genetics in Multiple Sclerosis

Basic Science, Resources

CMSC Recommendations for Care

Recommendations For Care, Resources

Spasticity Management In MS

Best Practices, Guidelines from other organizations, Resources

Defining Suboptimal Response to MS Treatment: MRI Outcome

2003 Consorcio de Centros de Esclerosis MúltipleProtocolo de RMI para el Diagnóstico y Seguimiento de la EM

2003 CMSC MRI Protocol for the Diagnosis and Follow-up of MS

ENS 2002 Guidelines for a standardized MRI protocol for MS

CMSC Consensus Statements, MRI

Immunizations And MS

Best Practices, Guidelines from other organizations, Resources

Disease Modifying Therapies In MS

Best Practices, Guidelines from other organizations, Resources

Fatigue: What Should You Know

Best Practices, Guidelines from other organizations, Resources

Urinary Dysfunction And MS

Best Practices, Guidelines from other organizations, Resources

Fatigue and MS

Best Practices, Guidelines from other organizations, Resources

Comments are closed.